CryoPort, Inc. (CYRX)
NASDAQIndustrialsIntegrated Freight & LogisticsSnapshot 2026-10-30
$17.29-5.47%
Close 2026-10-30 · 1-day change
NASDAQIndustrialsIntegrated Freight & LogisticsSnapshot 2026-10-30
Research Workspace
Put CYRX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Cash from operations exceeds $3.7 million quarterly: Comparison needs review.
View ThesisMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 32% in its worst 12-month stretch.
View RiskCYRX’s thesis rests on revenue growth supporting a sales multiple far above peers. Revenue grew 8% year over year in Q2 FY2026, and GAAP EPS was inline. CYRX trades at 5× sales versus the 2× peer median and 4× its own history. The price reflects less growth than our forecast, despite that premium. The next-quarter miss probability is 27%, and the cash-flow pillar needs review. Peer multiples imply a price about 15% below where it trades. The thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-30. CYRX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 9 analysts currently covering CYRX (as of Oct 2026).
Based on 5 Wall Street analysts offering 12-month price targets for CYRX in the last 4 months.
Continue this research
Compare CYRX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CYRX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Air Freight & Logistics — fair value, gap to price, and forward P/E.
Compare the value case
Put CYRX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase full-year revenue guidance
Analysts raising growth assumptions supports revenue guidance increase.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $17.29
The last 12 months of price, then the range of analyst 12-month targets from today’s $17.29.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
